The Penn Center for Innovation and Wharton San Francisco hosted more than 300 investors, corporate partners and Penn alumni for a program entitled Innovation@Penn: Programs and Partnerships during the recent J.P. Morgan Healthcare Investor Conference in San Francisco the first week of January. PCI’s 4th annual event provided an opportunity to further market and build interest in Penn’s portfolio of innovative activities and technologies emerging across campuses.
A keynote discussion featuring Melinda Richter (Global Head, Johnson & Johnson Innovation, JLABS) and Craig R. Carnaroli (Executive Vice President, University of Pennsylvania) was moderated by John Swartley (Managing Director, PCI). The discussion highlighted Penn’s new partnership at the Pennovation Center with the opening of the JPOD. The fireside session was followed by a panel of Penn’s neuroscientific innovators and startups including:
- Kacy Cullen, PhD, Research Associate Professor Of Neurosurgery
- Michael Platt, PhD, James S. Riepe University Professor
- Dan Rizzuto, PhD, Founder & CEO, Nia Therapeutics
- Steven Kelly, President and Chief Executive Officer of Carisma Therapeutics